{"type":"img","src":"https://cdn.quv.kr/w4tafv1qi%2Fup%2F5fdae57703138_1920.jpg","height":200}
  • Home
  • About
  • Science
  • Notice
  • Contact
  • {"google":["Muli","Lexend Deca","Poppins","Libre Baskerville"],"custom":["Noto Sans KR"]}
    ×
     
     
    섹션 설정
     
     
    섹션 설정
    {"type":"txt","text":"Mitos.Therapeutics","font_size":"22","font_weight":"normal","font_family_ko":"Noto Sans KR","font_family_en":"Lexend Deca","color":"rgb(94, 94, 94)","letter_spacing":0}
  • Home
  • About
  • Science
  • Notice
  • Contact
  • Mitos Therapeutics, Science

    #2

    Introduce Our Science

    Mitos.Therapeutics

    01. Sarcopenia

    More importantly, when sarcopenia is coupled with other diseases associated with aging, its affects can be even more pronounced. Loss of muscle mass and strength is a significant risk factor for disability in the aging population. When patients suffer from both sarcopenia and osteoporosis, the risk of falling and subsequent fracture incidence is higher. Therefore, treating sarcopenia will in turn help to lessen its burden on co-existing diseases.

    {"google":["Muli","Poppins","Questrial","Playfair Display","Alegreya"],"custom":["Noto Sans KR"]}{"google":["Muli","Lexend Deca","Poppins","Libre Baskerville","Questrial"],"custom":["Noto Sans KR"]}
    {"google":["Poppins"],"custom":["Noto Sans KR"]}